Article info

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

Authors

  1. Correspondence to Dr Alexandrosz Czira; Alexandrosz.x.czira{at}gsk.com
View Full Text

Citation

Czira A, Banks V, Requena G, et al
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

Publication history

  • Received March 7, 2022
  • Accepted August 27, 2022
  • First published September 28, 2022.
Online issue publication 
September 28, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.